Brought to you by:
Human-tissue engineered blood vessels remain durable at six years in PAD patients, latest study results show
Mid-term results from a phase II study of surgical bypass using the Human Acellular Vessel (HAV) demonstrated an overall secondary patency rate at 72 months of 60% measured by Kaplan Meier. There was no evidence of graft rejection or infection,…
MVSS 2022: Research on hemodialysis access surgery attracts inaugural Midwestern Vascular disparities award
The authors behind a new study that found “significant differences” in hemodialysis vascular access outcomes after first-time arteriovenous (AV) fistula or graft creation “directly related” to a patient’s race said the findings speak “to an injustice within the field of vascular surgery.” The research…
Registry data highlight long-term trends in hemodialysis access profile of failed kidney transplant patients
New findings, recently published in the Journal of Vascular Access (JVA), provide insight into the hemodialysis access profile of failed kidney transplant patients treated in the Catalonia region of Spain over an 18-year period. Researchers Ramon Roca-Tey, MD, a senior…
Intraoperative vascular mapping during hemodialysis access ‘should be incorporated into routine practice’
Intraoperative ultrasonographic venous mapping is a useful tool to evaluate vessel suitability for arteriovenous fistula (AVF) creation, Yana Etkin, MD, associate professor of surgery at the Zucker School of Medicine at Hofstra/Northwell in Lake Success, New York, concluded at the…
AVeVA study confirms benefit of covered stent placement in graft-vein anastomotic stenosis treatment
A prospective, multicenter study involving the Covera vascular covered stent (BD) has confirmed the benefits of immediate, post-percutaneous transluminal angioplasty (PTA) placement of the device in treating arteriovenous graft (AVG) venous anastomotic stenosis when anatomically and clinically suitable. Writing in the Journal…
First patient enrolled in Wrapsody endoprosthesis registry study
Merit Medical has announced the successful enrollment of the first patient in its WRAP registry study in a press release. The study will evaluate the clinical benefits associated with the use of the Wrapsody cell-impermeable endoprosthesis in patients receiving hemodialysis…
Medtronic issues voluntary recall for subset of IN.PACT Admiral and IN.PACT AV DCBs
Medtronic recently voluntarily recalled a subset of its IN.PACT Admiral and IN.PACT AV paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheters due to the potential for pouch damage resulting in a loss of sterility. This is according to a news alert…
Medical students reach out to hemodialysis community in times of COVID-19
As president of the Louisiana State University (LSU) Vascular Surgery Interest Group (VSIG), I’ve been eagerly exploring opportunities to engage with community members and uplift them on their journeys to improved health. As all are acutely aware, COVID-related restrictions on…
Houston, we have a dialysis access problem
The concept of dedicated vascular access centers fuels a turbocharged Texan tussle with Karl Illig, MD, of Flow Vascular Institute in Houston, taking on Eric Peden, MD, an associate professor of cardiovascular surgery at Houston Methodist Hospital, in a no-holds-barred debate…
‘Meet the Experts’ webinars now available OnDemand
Society for Vascular Surgery (SVS) members now have another chance to “Meet the Experts,” via computer screen and at no charge. Three of the “Meet the Experts” webinars held in spring and summer are now available on SVS OnDemand, part…